Available via license: CC BY-SA 4.0
Content may be subject to copyright.
Borneo Journal of Pharmacy http://journal.umpalangkaraya.ac.id/index.php/bjop/article/view/3153
Vol 5 Issue 2 May 2022 DOI: https://doi.org/10.33084/bjop.v5i2.3153
Page 153 – 160 e-ISSN: 2621-4814
INTRODUCTION
Acne (acne vulgaris) is a skin condition of the sebaceous glands that is characterized by the development of sebaceous
papules, cystic acne, inflammatory lesions, and involvement of the follicular canal and sebum production by
Propionibacterium acnes, Staphylococcus epidermidis, and Staphylococcus aureus1. Propionibacterium acnes was involved in
developing inflammatory acne by activating complements and metabolizing sebaceous triglycerides into fatty acids that
irritate the follicular wall and surrounding dermis2. Staphylococcus epidermidis usually involves in superficial infections within
the sebaceous unit3. Meanwhile, S. aureus growth could cause acne lesions4. Propionibacterium acnes, S. epidermidis, and S.
aureus can be the target sites of anti-acne drugs5.
The use of antibiotics to treat acne is usually done to reduce the bacterial population. However, overuse of antibiotics can
lead to antibiotic resistance. Therefore, it is necessary to explore local medicinal plants to develop anti-acne drugs6. Bawang
Dayak or Eleutherine bulbosa (Mill.) Urb.) is one of the notable Iridaceae family, originating from Central Kalimantan,
Indonesia. This plant is also widely cultivated in Southeast Asia. The bulb part has been used traditionally among the Dayak
community as folk medicine to treat several diseases7,8. Eleutherine bulbosa was known to have antibacterial properties against
acne-causing bacteria, as reported in our previous studies9-12. Our other previous studies13,14 also reported that cream of E.
bulbosa ethanol extract could inhibit the growth of P. acnes, and it does not cause significant skin adverse reactions15,16.
Formulation of Anti Acne Loose Powder of Bawang Dayak (Eleutherine
bulbosa (Mill.) Urb.) Ethanol Extract
Susi Novaryatiin*
Nursheilla Rizky Amalia
Syahrida Dian Ardhany
Department of Pharmacy, Universitas
Muhammadiyah Palangkaraya,
Palangka Raya, Central Kalimantan,
Indonesia
*email:
susi_novaryatiin@yahoo.com
Keywords:
Acne
Bawang dayak
Eleutherine bulbosa
Loose powder
Medicinal plant
Abstract
Bawang dayak (Eleutherine bulbosa (Mill.) Urb is one of the notable
Iridaceae family, originating from Central Kalimantan, Indonesia.
Previous studies have reported that E. bulbosa ethanol extract and its
cream preparation have antibacterial properties that can inhibit the
growth of acne-causing bacteria and cause no significant skin
adverse reaction. This study aimed to make a loose powder
preparation from E. bulbosa ethanol extract and determine its
physical evaluation and antibacterial activity. Loose powder
formulation was made with various concentrations of E. bulbosa
ethanol extract, F0 (0%), F1 (5%), F2 (10%), and F3 (15%). Loose
powder evaluates for organoleptic, homogeneity, and antibacterial
activity by the disc diffusion method. The results show that
E. bulbosa ethanol extract can produce a loose powder formulation.
The color of the formula is rather yellow (F0), brown-ash (F1), and
light brown (F2 and F3), which has a typical mint odor, smooth
texture, and homogeneous. All formulations inhibited the growth of
Propionibacterium acnes, Staphylococcus epidermidis, and
Staphylococcus aureus. This present study showed the potential of
Formula 3 (F3) as an anti-acne loose powder due to its organoleptic
properties, homogeneity, and antibacterial activity, which has the
largest inhibition zone diameter of 17.6 ± 3.1 mm.
Received: January 18th, 2022
Revised: May 10th, 2022
Accepted: May 18th, 2022
Published: May 31th, 2022
© 2022 Susi Novaryatiin, Nursheilla Rizky Amalia, Syahrida Dian Ardhany. Published by Institute for
Research and Community Services Universitas Muhammadiyah Palangkaraya. This is an Open Access article
under the CC-BY-SA License (http://creativecommons.org/licenses/by-sa/4.0/). DOI:
https://doi.org/10.33084/bjop.v5i2.3153
Research Article
Borneo Journal of Pharmacy, Vol 5 Issue 2, May 2022, Pages 153 – 160 e-ISSN: 2621-4814
154
However, it is necessary to make a series of anti-acne preparations to increase the effectiveness of using E. bulbosa as an anti-
acne. Topical products can be directly applied to the affected area, thus decreasing systemic absorption and increasing the
exposure of the pilosebaceous units to the acne treatment17. One of the preparations for topical application is a loose powder.
Loose powder is the original type of face powder that can easily absorb on the skin and free the face from oil18. Therefore,
this study aims to make innovative loose powder preparations from E. bulbosa ethanol extract and to determine its physical
evaluation and antibacterial activity. Formulating loose powder of E. bulbosa extract is needed as an alternative treatment for
acne. So, in the end, it can be produced anti-acne product series from E. bulbosa ethanol extract.
MATERIALS AND METHODS
Materials
The materials used were E. bulbosa bulbs, peppermint oil, ZnO, menthol, corn starch, sterile talcum, blank antimicrobial
susceptibility disc, strains of P. acnes ATCC 11827, S. epidermidis ATCC 12228, S. aureus ATCC 25923, Mueller-Hinton agar,
96% ethanol, NaCl, distilled water, branded loose powder (Wardah acnederm face powder). The main instruments used
include an analytical scale, oven, blender, autoclave, incubator, rotary evaporator, hot plate, laminar airflow, and caliper.
Methods
Collection of plant
Fresh bulbs of E. bulbosa were collected from Sei Gohong Village, Bukit Batu Sub-District, Palangka Raya, Central
Kalimantan, Indonesia. The plant was authenticated by Dr. Joeni Setijo Rahajoe from the Indonesian Institute of Sciences,
Research Center for Biology, with specimen voucher 2119.
Preparation of plant extract
The plant materials were prepared by cutting the bulbs and drying them in the sun no later than 10 AM. The dried plant
material is ground with a blender. The powdered plant materials were extracted by percolator using 96% ethanol. Then, a
rotary evaporator was used to concentrate all extracts14.
Formulation preparation
The formulation components used are listed in Table I. The components include ZnO, menthol, corn starch, sterile talcum,
and peppermint oil. The loose powder formulation of E. bulbosa ethanol extract was made with three concentrations, 5%,
10%, and 15%. Eleutherine bulbosa ethanol extract was weighed and dissolved in ethanol, then some corn starch and sterile
talcum were added and grounded until homogeneous. Meanwhile, menthol was dissolved with a bit of ethanol, then some
corn starch, sterile talcum, and ZnO were added and grounded until homogeneous. The mixture of E. bulbosa ethanol extract
was put into a mixture of menthol and ZnO, added peppermint oil, and grounded until homogeneous. The negative control
formulation (F0) was prepared in the same procedure without adding E. bulbosa ethanol extract. The homogeneous
formulation of loose powder was sieved through a 100-mesh sifter and packed19.
Table I. Formulation of loose powder of E. bulbosa ethanol extract
Material
Amount (mg)
Negative control or Formula 0 (F0)
Formula 1 (F1)
Formula 2 (F2)
Formula 3 (F3)
Eleutherine bulbosa ethanol extract
0
500
1000
1500
Peppermint oil
10 drops
10 drops
10 drops
10 drops
ZnO
300
300
300
300
Menthol
100
100
100
100
Corn starch
4000
4000
4000
4000
Sterile talcum ad
10000
10000
10000
10000
Physical evaluation of loose powder
There were two evaluations of physical properties: organoleptic and homogeneity tests20:
Novaryatiin S, Amalia NR, Ardhany SD. 2022. Formulation of Anti Acne Loose Powder of Bawang Dayak (Eleutherine bulbosa (Mill.) Urb.) …
155
1. Organoleptic test: Loose powder preparations that have been made were observed in color, odor, and texture.
2. Homogeneity test: The homogeneity test was done by visually observing the mixed color uniformity of the extract and
powder base. It was carried out by spreading the powder sample on a white paper.
Antibacterial activity test
A loose powder formulation was tested to determine an antibacterial activity against P. acnes, S. epidermidis, and S. aureus
using a disc-diffusion technique with three variations of concentration of 5%, 10%, and 15%. The 0.5 McFarland standard
was prepared, and 10 mL was put into sterile tubes. The bacterial suspension was made by diluting the bacterial colonies in
sterile physiological saline and adjusting the turbidity to 1-2x108 CFU/mL. A sterile cotton swab was dipped in a
standardized bacterial suspension and used for uniform inoculation onto Mueller-Hinton agar plates. Then, all the discs
were immersed in the solution of loose powder sample placed on the plates. A branded loose powder was used as a control.
Discs immersed in a solution of branded loose powder were also placed on the plates. These plates were then incubated for
24 hours at 37°C19. The diameter of the inhibition zone was measured in mm using a caliper. The study was repeated three
times for each loose powder formulation and control21.
RESULTS AND DISCUSSION
Physical evaluation of loose powder
Organoleptic test
An organoleptic test was carried out to see the physical appearance of the powder preparations by observing the color, odor,
and texture. The result of the organoleptic test showed that F0 had a rather yellow color, F1 had a brown ash color, while F2
and F3 had a light brown color (Table II). The color difference is due to differences in E. bulbosa ethanol extract concentration
in the formulations. All formulations had a typical mint odor and smooth texture based on the odor and texture. Typical
mint odor due to the addition of menthol and peppermint oil to the formulation to cover up the pungent odor of E. bulbosa.
The loose powder formulations of E. bulbosa ethanol extract can be seen in Figure 1.
Table II. Observations of organoleptic loose powder formulations
Formulation (% concentration of extract)
Texture
Color
Odor
F0 (0 %)
Smooth
Rather yellow
Typical mint
F1 (5 %)
Smooth
Brown ash
Typical mint
F2 (10%)
Smooth
Light brown
Typical mint
F3 (15%)
Smooth
Light brown
Typical mint
Homogeneity test
This study showed that all formulation was homogeneous. The homogeneity test of the loose powder aims to see whether
all the content is combined perfectly. Homogeneity is one of the requirements for the preparations of loose powder22. The
loose powder is said to be homogeneous if all the ingredients that make up the powder are well mixed and there are no
palpable ingredients.
Antibacterial activity test
The antibacterial activity was tested in triplicate against three acne-causing bacteria: P. acnes, S. epidermidis, and S. aureus.
Based on the zone of inhibition, it could be classified into four categories: weak (<5 mm), moderate (5-10 mm), strong (10-20
mm), and very strong (>20 mm)21,23. Meanwhile, based on the antibacterial activities of extracts can be classified into three
levels: weak activity (inhibition zone lower than 12 mm), moderate activity (inhibition zone between 12 and 20 mm), and
strong activity (inhibition zone higher than 20 mm)24.
Borneo Journal of Pharmacy, Vol 5 Issue 2, May 2022, Pages 153 – 160 e-ISSN: 2621-4814
156
Figure 1. The loose powder formulations: F0 (a), F1 (b), F2 (c) and F3 (d)
The results showed that two loose powder formulations of E. bulbosa ethanol extract (F1 and F2) had a weak inhibitory
response against S. aureus, while F3 showed moderate inhibitory power. F1 and F2 had a moderate inhibitory power against
S. epidermidis. However, F3 had a strong inhibitory response against S. epidermidis with an inhibition zone of 10.8 ± 0.8 mm.
Meanwhile, based on the classification of antibacterial activities of extract24, the three formulations (F1, F2, F3) had a weak
activity against S. epidermidis and S. aureus, with the inhibition zones in the range of 2.9 ± 1.4 to 10.8 ± 0.8 mm. Furthermore,
the antibacterial activity of the three formulations can be described as strong against P. acnes. The highest zone of inhibition
produced by F3 was 17.6 ± 3.1 mm (Table III and Figure 2). This can occur due to differences in E. bulbosa ethanol extract
concentration in each formulation. The higher the E. bulbosa ethanol extract concentration in the formulation, the higher the
inhibition zone produced21.
The ability to produce the clear zone was presumably dependent on the secondary metabolites possessed by the test
sample25. This finding was due to flavonoids, alkaloids, saponins, and tannins in E. bulbosa ethanol extract11, which could be
responsible for the antibacterial properties observed. Eleutherol A, a flavonoid from E. bulbosa, inhibits cell wall synthesis in
bacteria26. Alkaloids have an antibacterial ability and generally work through efflux pump inhibition activity. Most of the
alkaloids are found to be bactericidal rather than bacteriostatic27,28. Saponins can cause bacterial cell contents' leakage through
cell wall degradation followed by disruption of the cytoplasmic membrane and membrane proteins29. Tannins were known
to have antibacterial properties against Gram-negative and Gram-positive human pathogens30,31.
A previous study32 reported that an anti-acne loose powder of ethanol extract of Piper betle leaves had antibacterial activity
against one acne-causing bacteria, S. aureus. The inhibition zones of loose powder formulation of F1 (0%), F2 (5%), F3 (10%)
and F4 (15%) were 1.05 mm, 5 mm, 6.11 mm, and 6.31 mm. The inhibition zones produced in this study were greater on a
concentration of 15% of E. bulbosa ethanol extract in loose powder formulation (F3) against S. aureus, which is 7.9 ± 1.5 mm.
Table III. The inhibition zone of loose powder formulation of E. bulbosa ethanol extract and control
Formulation (% concentration of extract)
Zone of inhibition (mm) (mean ± SD; n=3)
P. acnes
S. epidermidis
S. aureus
F0 (0%)
6.0 ± 2.7
7.1 ± 0.4
2.1 ± 0.5
F1 (5%)
12.8 ± 0.1
6.6 ± 1.6
2.9 ± 1.4
F2 (10%)
16.1 ± 1.6
9.1 ± 0.5
4.1 ± 1.2
F3 (15%)
17.6 ± 3.1
10.8 ± 0.8
7.9 ± 1.5
Control
1.1 ± 0.2
1.8 ± 0.5
1.6 ± 0.7
Novaryatiin S, Amalia NR, Ardhany SD. 2022. Formulation of Anti Acne Loose Powder of Bawang Dayak (Eleutherine bulbosa (Mill.) Urb.) …
157
Figure 2. The antibacterial activity of loose powder formulation of E. bulbosa ethanol extract against P. acnes (a), S. epidermidis (b) and S.
aureus (c)
Negative control (F0) also showed the inhibition zones against three bacterial tested. It can be caused by the presence of zinc
oxide. Zinc oxide is known for its antioxidant properties and has been shown to help prevent UV damage. It is used for
several dermatological conditions, including infections (warts, leishmaniasis), dermatitis (acne vulgaris, rosacea),
pigmentary disorders (melasma), and neoplasias (basal cell carcinoma), and due to its non-toxicity, biocompatibility and
antibacterial activity33.
This study used a branded loose powder (Wardah acnederm face powder) as a control. It contains mica, corn (Zea mays)
starch, kaolin, silica, zinc stearate, aqua, phenoxyethanol, dimethicone, salicylic acid, ethylhexylglycerin, hydrogen
dimethicone, methicone, allantoin, Epilobium angustifolium flower/leaf/stem extract, fragrance, aluminum hydroxide,
butylene glycol, sodium metabisulfite, Glycine soja (soybean) protein, tocopherol. Salicylic acid, Epilobium angustifolium
flower/leaf/stem extract, and soybean protein are commonly used for acne treatment and have antibacterial activity34-36.
The antibacterial activity of control was categorized as weak, with the inhibition zones against P. acnes, S. epidermidis, and S.
aureus being less than 2 mm. When compared, the inhibition zones resulting from the three formulations of loose powder
of E. bulbosa ethanol extract were more significant than the inhibition zones of the positive control. Therefore, it can be
concluded that the loose powder formulation of E. bulbosa ethanol extract has better antibacterial activity against three
bacteria that can cause acne.
CONCLUSION
Eleutherine bulbosa ethanol extract can be processed into a loose powder formulation. The color of the formula is rather yellow
(F0), brown-ash (F1), and light brown (F2 and F3). Moreover, it has a typical mint odor, smooth texture, and is homogeneous.
The highest zone of inhibition produced by F3 (15%) against P. acnes was 17.6 ± 3.1 mm. This present study showed the
potential of formulation as anti-acne, but further research is needed to do irritation tests in rabbits and on human skin so it
can be developed as an anti-acne loose powder product.
Borneo Journal of Pharmacy, Vol 5 Issue 2, May 2022, Pages 153 – 160 e-ISSN: 2621-4814
158
ACKNOWLEDGMENT
The authors thank to the laboratory of Faculty of Health Sciences, Universitas Muhammadiyah Palangkaraya, for providing
the necessary facilities for carrying out this study.
AUTHORS’ CONTRIBUTION
Susi Novaryatiin: conceptualization, funding acquisition, methodology, visualization, writing-original draft, writing-
review & editing. Nursheilla Rizky Amalia: formal analysis, investigation, project administration, resources. Syahrida
Dian Ardhany: conceptualization, funding acquisition, methodology, supervision, validation.
DATA AVAILABILITY
None.
CONFLICT OF INTEREST
The authors declare no conflict of interest.
REFERENCES
1. Xu H, Li H. Acne, the Skin Microbiome, and Antibiotic Treatment. Am J Clin Dermatol. 2019;20(3):335-44.
doi:10.1007/s40257-018-00417-3
2. McLaughin J, Watterson S, Layton AM, Bjourson AJ, Barnard E, McDowell A. Propionibacterium acnes and Acne
Vulgaris: New Insights from the Integration of Population Genetic, Multi-Omic, Biochemical and Host-Microbe Studies.
Microorganisms. 2019;7(5):128. doi:10.3390/microorganisms7050128
3. Fodter TJ. Surface Proteins of Staphylococcus epidermidis. Front Microbiol. 2020;11:1829. doi:10.3389/fmicb.2020.01829
4. Khorvash F, Abdi F, Kashani HH, Naeini FF, Narimani T. Staphylococcus aureus in Acne Pathogenesis: A Case-Control
Study. N Am J Med Sci. 2012;4(11):573-6. doi:10.4103/1947-2714.103317
5. Blaskovich MAT, Elliott AG, Kavanagh AM, Ramu S, Cooper MA. In vitro Antimicrobial Activity of Acne Drugs
Against Skin-Associated Bacteria. Sci Rep. 2019;9(1):14658. doi:10.1038/s41598-019-50746-4
6. Nasri H, Bahmani M, Shahinfard N, Nafchi AM, Saberianpour S, Kopaei MR. Medicinal Plants for the Treatment of
Acne Vulgaris: A Review of Recent Evidences. Jundishapur J Microbiol. 2015;8(11):e25580. doi:10.5812/jjm.25580
7. Kamarudin AA, Sayuti NH, Saad N, Razak NAA, Esa NM. Eleutherine bulbosa (Mill.) Urb. Bulb: Review of the
Pharmacological Activities and Its Prospects for Application. Int J Mol Sci. 2021;22(13):6747. doi:10.3390/ijms22136747
8. Wiendy NMA, Maulida N, Krisantini K. Biology and Bulb Production of Eleutherine bulbosa (Iridaceae), a Native
Species from Borneo, Indonesia. Ornam Hortic. 2021;27(2):232-7. doi:10.1590/2447-536X.v27i2.2269
9. Novaryatiin S, Pratiwi AM, Ardhany SD. Uji Daya Hambat Ekstrak Etanol Bawang Dayak (Eleutherine bulbosa (Mill.)
Urb.) Terhadap Bakteri Staphylococcus epidermidis. Anterior J. 2018;18(1):92-7. doi:10.33084/anterior.v18i1.392
10. Novaryatiin S, Ramli A, Ardhany SD. Uji Daya Hambat Ekstrak Etanol Bawang Dayak (Eleutherine bulbosa (Mill.) Urb.)
Terhadap Bakteri Staphylococcus aureus. J Surya Medika. 2019;4(2):51-9. doi:10.33084/jsm.v4i2.565
Novaryatiin S, Amalia NR, Ardhany SD. 2022. Formulation of Anti Acne Loose Powder of Bawang Dayak (Eleutherine bulbosa (Mill.) Urb.) …
159
11. Novaryatiin S, Ardhany SD. The Antibacterial Activity of Bawang Dayak (Eleutherine bulbosa (Mill.) Urb.) from Central
Kalimantan Against Acne-Causing Bacteria. Int J App Pharm. 2019;11(5):22-5. doi:10.22159/ijap.2019.v11s5.T0032
12. Novaryatiin S, Ardhany SD. Potential Anti-acne: Bawang Dayak (Eleutherine bulbosa (Mill.) Urb.) from Central
Kalimantan-Indonesia. Pharmacogn J. 2020;12(1):52-7. doi:10.5530/pj.2020.12.9
13. Ardhany SD, Novaryatiin S. 2019. Antibacterial Activity of Ethanolic Extract Bawang Dayak (Eleutherine bulbosa (Mill.)
Urb.) in Cream Against Propionibacterium acnes. Int J App Pharm. 2019;11(5):1-4. doi:10.22159/ijap.2019.v11s5.T0020
14. Ardhany SD, Putra CD, Novaryatiin S. Modification of Anti-acne Bawang Dayak (Eleutherine Bulbosa (Mill.) Urb.)
Cream to Propionibacterium Acnes. J Adv Pharm Technol Res. 2021;12(1):94-8. doi:10.4103/japtr.JAPTR_107_20
15. Ardhany SD, Effendie RR, Novaryatiin S. Uji Iritasi Formulasi Sediaan Krim Ekstrak Bawang Dayak (Eleutherine
bulbosa (Mill.) Urb.) pada Kelinci Albino Putih. J Surya Medika. 2019;5(1):63-9. doi:10.33084/jsm.v5i1.946
16. Ardhany SDA, Novaryatiin S, Pratama MRF, Utar Z. Irritation Test of Bawang Dayak (Eleutherine Bulbosa (Mill.) Urb.)
Extract Cream with Human Patch Test Method. J Farmasi Sains Praktis. 2021;7(1):74-80.
doi:10.31603/pharmacy.v7i1.4854
17. Fox L, Csongradi C, Aucamp M, du Plessis J, Gerber M. Treatment Modalities for Acne. Molecules. 2016;21(8):1063.
doi:10.3390/molecules21081063
18. Bamford E, Grahn A, Århammar C, Ajaxon I, Annerén C. Mesoporous magnesium carbonate for use in powder
cosmetics. Int J Cosmet Sci. 2021;43(1):57-67. doi:10.1111/ics.12670
19. Gallo L, Ramírez-Rigo MV, Piña J, Palma S, Allemandi D, Bucalá V. Valeriana officinalis Dry Plant Extract for Direct
Compression: Preparation and Characterization. Sci Pharm. 2012;80(4):1013-26. doi:10.3797/scipharm.1206-05
20. Inoue Y, Suzuki K, Maeda R, Shimura A, Murata I, Kanamoto I. Evaluation of formulation properties and skin
penetration in the same additive-containing formulation. Results Pharma Sci. 2014;4:42-9.
doi:10.1016/j.rinphs.2014.09.003
21. Dewi AP, Mardhiyani D. Formulation and Antibacterial Activity of Liquid Soap Containing Ketapang (Terminalia
catappa L.) Leaves Extract. Borneo J Pharm. 2021;4(1):43-50. doi:10.33084/bjop.v4i1.1589
22. Marianni B, Polonini H, Oliveira MAL. Ensuring Homogeneity in Powder Mixtures for Pharmaceuticals and Dietary
Supplements: Evaluation of a 3-Axis Mixing Equipment. Pharmaceutics. 2021;13(4):563.
doi:10.3390/pharmaceutics13040563
23. Davis WW, Stout TR. Disc Plate Method of Microbiological Antibiotic Assay: I. Factors Influencing Variability and Error.
Appl Microbiol. 1971;22(4):659-65. doi:10.1128/am.22.4.659-665.1971
24. Shahbazi Y. Antibacterial and Antioxidant Properties of Methanolic Extracts of Apple (Malus pumila), Grape (Vitis
vinifera), Pomegranate (Punica granatum L.) and Common Fig (Ficus carica L.) Fruits. Pharm Sci. 2017;24(4):308-15.
doi:10.15171/PS.2017.45
25. Ouchari L, Boukeskasse A, Bouizgarne B, Ouhdouch Y. Antimicrobial Potential of Actinomycetes Isolated from The
Unexplored Hot Merzouga Desert and Their Taxonomic Diversity. Biol Open. 2019;8(2):bio035410.
doi:10.1242/bio.035410
26. Pratama MRF, Aziz IR. Molecular Docking of Bawang Dayak (Eleutherine bulbosa) Secondary Metabolites as Bacterial
Cell Wall Synthesis Inhibitor. Proceedings of the 1st International Conference on Science and Technology; 2019 May 2-3;
Makassar, Indonesia. Ghent: EAI; 2019. doi:10.4108/eai.2-5-2019.2284686
27. Thawabteh A, Juma S, Bader M, Karaman D, Scrano L, Bufo SA, et al. The Biological Activity of Natural Alkaloids
Against Herbivores, Cancerous Cells and Pathogens. Toxins. 2019;11(11):656. doi:10.3390/toxins11110656
Borneo Journal of Pharmacy, Vol 5 Issue 2, May 2022, Pages 153 – 160 e-ISSN: 2621-4814
160
28. Khameneh B, Iranshahy M, Soheili V, Bazzaz BSF. Review on Plant Antimicrobials: A Mechanistic Viewpoint.
Antimicrob Resist Infect Control. 2019;8:118. doi:10.1186/s13756-019-0559-6
29. Dong S, Yang X, Zhao L, Zhang F, Hou Z, Xue P. Antibacterial Activity and Mechanism of Action Saponins from
Chenopodium quinoa Willd. Husks Against Foodborne Pathogenic Bacteria. Ind Crop Prod. 2020;149:112350.
doi:10.1016/j.indcrop.2020.112350
30. Kurhekar JV. Tannins-Antimicrobial Chemical Components. Int J Technol Sci. 2016;9(3):5-9.
31. Maisetta G, Batoni G, Caboni P, Esin S, Rinaldi AC, Zucca P. Tannin Profile, Antioxidant Properties, and Antimicrobial
Activity of Extracts from Two Mediterranean Species of Parasitic Plant Cytinus. BMC Complement Altern Med.
2019;19:82. doi:10.1186/s12906-019-2487-7
32. Rasydy LOA, Supriyanta J, Novita D. Formulasi Ekstrak Etanol 96% Daun Sirih Hijau (Piper betle L.) dalam Bedak
Tabur Anti Jerawat dan Uji Aktivitas Antiacne Terhadap Staphylococcus aureus. J Farmagazine. 2019;6(2):18-26.
doi:10.47653/farm.v6i2.142
33. Gupta M, Mahajan VK, Mehta KS, Chauhan PS. Zinc therapy in dermatology: a review. Dermatol Res Pract.
2014;2014:709152. doi:10.1155/2014/709152
34. Chaleshtori SAH, Kachoie MA, Jazi SMH. Antibacterial Effects of The Methanolic Extract of Glycine Max (Soybean).
Microbiol Res. 2017;8(2):7319. doi: https://doi.org/10.4081/mr.2017.7319
35. Dhayakaran R, Neethirajan S, Weng X.Investigation of The Antimicrobial Activity of Soy Peptides by Developing a High
Throughput Drug Screening Assay. Biochem Biophys Rep. 2016;6:149-57. doi:10.1016/j.bbrep.2016.04.001
36. Yüksel AK, Dikici E, Yüksel M, Işık M, Tozoğlu F, Köksal E. Phytochemical, Phenolic Profile, Antioxidant,
Anticholinergic and Antibacterial Properties of Epilobium angustifolium (Onagraceae). J Food Meas Charact.
2021;15(6):4858–67. doi:10.1007/s11694-021-01050-1
